Literature DB >> 10679908

Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer.

F Riedel1, K Götte, W Bergler, W Rojas, K Hörmann.   

Abstract

BACKGROUND: Angiogenesis is crucial for tumor growth and metastasis. In several tumors, microvascular density has been shown to correlate with metastasis and aggressiveness. Basic fibroblast growth factor (bFGF) has potent angiogenic activity and has been identified in a wide variety of malignancies including head and neck squamous cell carcinomas (HNSCC). Material and Methods Frozen sections of 50 HNSCC were immunostained for von Willebrand factor and bFGF. Microvessels were counted by light microscopy; bFGF expression was studied at the light and electron microscopic level. Laryngeal cancer cell line HlaC79 was incubated with interferon (IFN) alpha and beta. bFGF quantification was performed by ELISA, and antiproliferative effects were determined by BrdU assay.
RESULTS: The mean number of blood vessels (77.5 +/- 23.7) is significantly increased in HNSCC compared with controls (17.1 +/- 5.9). bFGF protein expression was detected in all HNSCC but not in control tissue. An correlation between bFGF expression and mean number of microvessels was found (p <.001). However, no correlation between bFGF expression and the main clinicopathologic features was shown. The long-term exposure (144 hr) of HNSCC cells to noncytostatic concentrations of IFN alpha and beta (>10 U/mL) down-regulated the protein production of bFGF.
CONCLUSION: bFGF expression and angiogenesis are enhanced in HNSCC. The higher microvessel density in HNSCC with strong bFGF expression supports the importance of bFGF for tumor angiogenesis. IFN alpha and beta treatment leads to a down-regulation of bFGF expression independent of their antiproliferative effects, suggesting that IFN treatment might result in a reduction of angiogenesis in HNSCC. Copyright 2000 John Wiley & Sons, Inc. Head Neck 22: 183-189, 2000.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679908     DOI: 10.1002/(sici)1097-0347(200003)22:2<183::aid-hed11>3.0.co;2-r

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma.

Authors:  E R Salter; D Tichansky; E E Furth; A M Herlyn
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

2.  Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.

Authors:  Caroline Aspord; Laetitia Tramcourt; Claire Leloup; Jean-Paul Molens; Marie-Therese Leccia; Julie Charles; Joel Plumas
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

3.  Head and Neck Squamous Cell Cancer: Biology (II) and Translational Methods.

Authors:  Anupam Mishra; Amita Pandey; Xiaolin Nong
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-10-05

4.  Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways.

Authors:  Wei-Zhong Wu; Hui-Chuan Sun; Yue-Fang Shen; Jie Chen; Lu Wang; Zhao-You Tang; George Iliakis; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-11       Impact factor: 4.553

5.  Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.

Authors:  Dhruv Kumar; Jacob New; Vikalp Vishwakarma; Radhika Joshi; Jonathan Enders; Fangchen Lin; Sumana Dasari; Wade R Gutierrez; George Leef; Sivapriya Ponnurangam; Hemantkumar Chavan; Lydia Ganaden; Mackenzie M Thornton; Hongying Dai; Ossama Tawfik; Jeffrey Straub; Yelizaveta Shnayder; Kiran Kakarala; Terance Ted Tsue; Douglas A Girod; Bennett Van Houten; Shrikant Anant; Partha Krishnamurthy; Sufi Mary Thomas
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

Review 6.  Management of angiosarcoma.

Authors:  G Thomas Budd
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

7.  Ultrasound backscatter microscopy for imaging of oral carcinoma.

Authors:  Matthew Lam; Abhijit J Chaudhari; Yang Sun; Feifei Zhou; Allison Dobbie; Regina F Gandour-Edwards; Steve P Tinling; D Gregory Farwell; Wayne L Monsky; K Kirk Shung; Laura Marcu
Journal:  J Ultrasound Med       Date:  2013-10       Impact factor: 2.153

8.  Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer.

Authors:  K Araki; T Yamashita; N Reddy; H Wang; W M Abuzeid; K Khan; B W O'Malley; D Li
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.